A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer

Icli, F; AKBULUT, HAKAN; Dincol, D; Onur, H; DEMİRKAZIK, AHMET; Cam, R; Cay, F; Demirci, S; Uner, A; Erekul, S

doi:10.1023/a:1011118004629

A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer

Icli F., AKBULUT H., Dincol D., Onur H., DEMİRKAZIK A., Cam R., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.12, sa.7, ss.1011-1013, 2001 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12 Sayı: 7
Basım Tarihi: 2001
Doi Numarası: 10.1023/a:1011118004629
Dergi Adı: ANNALS OF ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1011-1013
Anahtar Kelimeler: adjuvant chemotherapy, adriamycin, breast cancer, cisplatin, cyclophosphamide, etoposide, CHEMOTHERAPY, DOXORUBICIN
Ankara Üniversitesi Adresli: Evet

Özet

Background: Four cycles of AC have been accepted as the standard chemotherapy in breast cancer. In the present randomized study we aimed to assess the efficacy of adjuvant etoposide + cisplatin (EP) combination following four cycles of standard adriamycin + cyclophosphamide (AC) in premenopausal patients with operable breast cancer and axillary lymph node metastasis.